Status:
COMPLETED
Improving Access to HbA1c in Sub Saharan Africa
Lead Sponsor:
Yaounde Central Hospital
Collaborating Sponsors:
Newcastle University
University of Yaounde 1
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glycated haemoglobin (HbA1c) is the best surrogate of average blood glucose control in diabetic patients. Large-scale studies in the USA and UK have demonstrated that lowering HbA1c significantly redu...
Detailed Description
The objective is to determine whether the introduction of routine affordable HbA1c determination with immediate feedback to patients and relevant education in an underserved population without any fur...
Eligibility Criteria
Inclusion
- Confirmed diabetes mellitus irrespective of type
- Patients who have been followed regularly for at least one year prior to inclusion in the target health facilities
- Adult age (18 years and over)
Exclusion
- Individuals planning to migrate from study sites within one year
- Any intercurrent acute illness
- Enrollment in any other concomitant intervention study
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
1349 Patients enrolled
Trial Details
Trial ID
NCT01460095
Start Date
March 1 2009
End Date
December 1 2011
Last Update
April 19 2016
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Yaounde Central Hospital
Yaoundé, Centre Region, Cameroon
2
Garoua Regional Hospital
Garoua, North Region, Cameroon
3
Bamenda Regional Hospital
Bamenda, North-West Region, Cameroon
4
Buea Regional Hospital
Buea, South-West Region, Cameroon